ADAR and Miyoshi myopathy: K-M analysis revealed that patients in the groups with lower expression of FASKD1, SNRPD3, DDX21, MRPL3, ADAR, CPSF3, DROSHA, and CAPRIN2 and higher expression of SART1 had better survival (Figure 2), suggesting that FASKD1, SNRPD3, DDX21, MRPL3, ADAR, CPSF3, DROSHA, CAPRIN2 and SART1 might play important roles in the prognosis of MM patients.